# Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy

> **NCT00328302** · PHASE4 · UNKNOWN · sponsor: **Karolinska University Hospital** · enrollment: 13 (—)

## Conditions studied

- Diabetes, Type I

## Interventions

- **DRUG:** Candesartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00328302
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 13 (—)
- **Last updated:** 2006-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328302, "Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00328302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*